Originally posted here: Roche to present new data in blood cancers and solid tumours from its broad portfolio at ASCO 2023
Originally posted here: Roche to present new data in blood cancers and solid tumours from its broad portfolio at ASCO 2023
See the original post: Novo Nordisk A/S: Once-weekly Sogroya® (somapacitan) receives CHMP positive opinion for expanded use in children and adolescents with growth hormone...
Follow this link: Castellum, Inc. Announces $6 million Cost Reduction Plan
Originally posted here: Curium Receives Positive CHMP Opinion of PYLCLARI® for Primary Staging of Patients With High-Risk PCa Prior to Initial Curative Therapy and to...
See more here: Talaris Therapeutics Announces Leadership Transition
See more here: BioSyent Releases Financial Results for Q1 2023
See more here: Data Demonstrating Long-Term Improvement in Depression in Cancer Patients Following Single Dose of COMP360 Psilocybin Therapy to be Presented at ASCO...
Read the original here: Ipsen receives CHMP negative opinion, following re-examination of potential first FOP treatment in the E.U.
Read the original post: Immutep Announces Publication of Abstracts for ASCO 2023 Annual Meeting
Go here to read the rest: Neuronetics Announces Increased TMS Access Through BlueCross BlueShield Of Michigan
Recent Comments